| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 406FL5G00V |
| Parent Compound: | RIGOSERTIB |
| InChI Key | VLQLUZFVFXYXQE-USRGLUTNSA-M |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H24NNaO8S |
| Molecular Weight | 473.48 |
| AlogP | 2.8 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 11.0 |
| Polar Surface Area | 120.39 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 31.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Anemia, Refractory, with Excess of Blasts | 3 | D000754 | ClinicalTrials |
| Leukemia, Myelomonocytic, Chronic | 3 | D015477 | ClinicalTrials |
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
| Epidermolysis Bullosa Dystrophica | 0 | D016108 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 145421 |
| ChEMBL | CHEMBL2013119 |
| FDA SRS | 406FL5G00V |
| PubChem | 23696523 |
| SureChEMBL | SCHEMBL498729 |